Suchergebnisse - "Jimeno, A"

PubPharm (230)

61

Pembrolizumab: PD-1 inhibition as a therapeutic strategy in cancer

enthalten in: Drugs of today | 2015

von McDermott, J. | Jimeno, A.

62

Apatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumors

enthalten in: Drugs of today | 2015

von Scott, A. | Messersmith, W. | Jimeno, A.

63

Nintedanib, a novel triple angiokinase inhibitor for the treatment of non-small cell lung cancer

enthalten in: Drugs of today | 2015

von Noonan, S. | Man Wong, K. | Jimeno, A.

64

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2014

von Fulchiero, E. | Jimeno, A.

65

23 Phase I study of lurbinectedin (PM01183) administered on days (D) 1 & 8 every 3 weeks (q3wk) in patients (pts) with solid tumors

enthalten in: The European journal of cancer / A | 2014

von Ratain, M. | Gore, L. | Szyldergemajn, S. | +6

66

Panitumumab in the treatment of colon cancer : A biomarker dilemma

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2014

von Scott, A. | Messersmith, W. | Jimeno, A. | +1

67

Safety and Feasibility Update of Olaparib, an Orally Bioavailable PARP Inhibitor, With Concurrent Cetuximab and Radiation Therapy in Heavy Smokers With Stage III-IVB Squamous Cell Carcinoma of the Head/Neck: A Phase 1 Trial

enthalten in: International journal of radiation oncology, biology, physics | 2014

von Waxweiler, T. | Bowles, D. | Reddy, K. | +6

68

Radiation Dose Uncertainty in a Mouse Head and Neck Irradiation Model

enthalten in: International journal of radiation oncology, biology, physics | 2014

von Gan, G. | Eagles-Soukup, J. | Raben, D. | +2

69

Belinostat for the treatment of peripheral T-cell lymphomas

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2014

von McDermott, J. | Jimeno, A.

70

Ibrutinib for the treatment of chronic lymphocytic leukemia and mantle cell lymphoma

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2014

von McDermott, J. | Jimeno, A.